ENANTA PHARMACEUTICALS, INC Available-for-sale Securities
ENANTA PHARMACEUTICALS, INC (ENTA) had Available-for-sale Securities of $221.98 million as of 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-05-10
- 2018-03-31: Available-for-sale Securities $221.98M.
- 2017-12-31: Available-for-sale Securities $229.44M.
- 2017-09-30: Available-for-sale Securities $228.03M.
- 2017-06-30: Available-for-sale Securities $213.07M.
| Period end | Available-for-sale Securities |
|---|---|
| 2018-03-31 | $221.98M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $229.44M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $228.03M 10-Q · filed 2018-05-10 |
| 2017-06-30 | $213.07M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $221.69M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $223.78M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $225.63M 10-K · filed 2017-12-11 |
| 2016-06-30 | $219.87M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $189.29M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $190.40M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $187.72M 10-K · filed 2016-12-09 |
| 2015-06-30 | $192.10M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $201.05M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $93.46M 10-Q · filed 2015-02-06 |
| 2014-09-30 | $101.07M 10-K · filed 2015-12-11 |
| 2014-06-30 | $111.21M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $83.85M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $101.74M 10-Q · filed 2014-02-13 |
| 2013-09-30 | $103.32M 10-K · filed 2014-12-11 |
| 2013-06-30 | $95.89M 10-Q · filed 2013-08-12 |
| 2012-09-30 | $34.91M 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |